However, the proteasome inhibitors MG132 and bortezomib, which also provoke ER stress, significantly upregulated PHLDA1 and PHLDA2 protein and mRNA expression in HEK293 and in various cancer cells (Fig. 10a, b and Supplementary Fig. 9e). Here, PHLDA2 is linked to cancer.